Near-Infrared Spectroscopy Shows Promise in Detecting Uterine Cancer and Fibroids
Researchers at Columbia University have made a groundbreaking discovery in the field of gynecologic imaging, using near-infrared spectroscopy (NIRS) to detect uterine cancer and fibroids with a high degree of accuracy. According to a recent study published in the Journal of Biophotonics, the team was able to classify normal, cancerous, and fibroid tissues with remarkable precision using NIRS spectral contrast parameters. This innovative approach has significant implications for early diagnosis and treatment of these common uterine pathologies.
Key Takeaways:
- The study used NIRS spectral features to analyze 69 surgical specimens from 24 patients, achieving a prediction accuracy of over 70% in classifying normal, cancerous, and fibroid tissues.
- The classification model was able to identify cancer specimens with 70% sensitivity and 93% specificity, and fibroid samples with 86% sensitivity and 83% specificity.
- The research found significant optical features and spectral principal components that allowed for accurate differentiation between tissue types.
- The study suggests that NIRS mapping has promise as a complementary method for gynecologic imaging.
- The research was supported by the Avanessians Data Fellowship, Columbia Engineering STAR Award, Columbia University Provost, Wei Family Foundation Graduate Fellowship, and NIH/NCI Cancer Center Support Grant.
- The study was conducted by a team of researchers at Columbia University, including Christine P. Hendon, Danyang Cheng, Haiqiu Yang, Arielle S. Joasil, Xiaowei Chen, and Hanina Hibshoosh.
Statistics:
- 69 surgical specimens were analyzed from 24 patients.
- The classification model achieved a prediction accuracy of over 70%.
- 70% sensitivity and 93% specificity were achieved in identifying cancer specimens.
- 86% sensitivity and 83% specificity were achieved in identifying fibroid samples.
- The research was supported by multiple grants, including the Avanessians Data Fellowship, Columbia Engineering STAR Award, and NIH/NCI Cancer Center Support Grant.
Sources:
- NewsRx. Recent Findings in Leiomyomas Described by Researchers from Columbia University (Near-infrared Spectroscopy Mapping for Uterine Cancer and Fibroid Detection). Health & Medicine Week. June 20, 2025; p 3368.
- "Near-infrared Spectroscopy Mapping for Uterine Cancer and Fibroid Detection". Journal of Biophotonics, 2025.
- Journal of Biophotonics. Contact information: Wiley-v C H Verlag Gmbh, Postfach 101161, 69451 Weinheim, Germany.